ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 479,40
-0,68%
Dow Jones
39 118,86
-0,12%
DAX
18 235,45
0,17%
Brent Oil
84,85
0,00%
Bitcoin
60 871,84
0,93%
Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Ventyx Biosciences Inc (VTYX)

  7. Ventyx Biosciences Inc (VTYX) Actualités

VTYX

Ventyx Biosciences (VTYX)

Ventyx Biosciences Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:VTYX
DateHeureSourceTitreSymboleSociété
11/06/202422h47Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VTYXVentyx Biosciences Inc
06/06/202422h05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VTYXVentyx Biosciences Inc
05/06/202422h01GlobeNewswire Inc.Ventyx Biosciences Announces Positive Preclinical Data for CNS-Penetrant NLRP3 Inhibitor VTX3232 Demonstrating Reversal of Obesity and Improvements in Cardiometabolic and Inflammatory MarkersNASDAQ:VTYXVentyx Biosciences Inc
16/05/202422h05GlobeNewswire Inc.Ventyx Biosciences to Participate in Three Upcoming Investor ConferencesNASDAQ:VTYXVentyx Biosciences Inc
16/05/202414h00GlobeNewswire Inc.Ventyx Biosciences Announces Appointment of Matthew Moore as Chief Operating OfficerNASDAQ:VTYXVentyx Biosciences Inc
09/05/202422h16Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:VTYXVentyx Biosciences Inc
09/05/202422h01GlobeNewswire Inc.Ventyx Biosciences Reports First Quarter 2024 Financial Results and Highlights Recent Corporate ProgressNASDAQ:VTYXVentyx Biosciences Inc
02/05/202422h05GlobeNewswire Inc.Ventyx Biosciences to Report First Quarter 2024 Financial Results on May 9, 2024NASDAQ:VTYXVentyx Biosciences Inc
26/04/202411h45PR Newswire (US)The Gross Law Firm Reminds Ventyx Biosciences, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of April 30, 2024 - VTYXNASDAQ:VTYXVentyx Biosciences Inc
19/04/202412h00PR Newswire (US)Ventyx Biosciences, Inc. Securities Fraud Class Action Lawsuit Pending: Contact The Gross Law Firm Before April 30, 2024 to Discuss Your Rights - VTYXNASDAQ:VTYXVentyx Biosciences Inc
16/04/202411h45PR Newswire (US)The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of April 30, 2024 in Ventyx Biosciences, Inc. Lawsuit - VTYXNASDAQ:VTYXVentyx Biosciences Inc
09/04/202412h10PR Newswire (US)Investors in Ventyx Biosciences, Inc. Should Contact The Gross Law Firm Before April 30, 2024 to Discuss Your Rights - VTYXNASDAQ:VTYXVentyx Biosciences Inc
05/04/202411h45PR Newswire (US)Investors who lost money on Ventyx Biosciences, Inc.(VTYX) should contact The Gross Law Firm about pending Class Action - VTYXNASDAQ:VTYXVentyx Biosciences Inc
26/03/202410h45PR Newswire (US)Ventyx Biosciences, Inc. Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm for More Information - VTYXNASDAQ:VTYXVentyx Biosciences Inc
11/03/202412h00GlobeNewswire Inc.Ventyx Biosciences Reports Clinical Data for its NLRP3 Inhibitor Portfolio and Provides Pipeline Updates at Virtual Investor EventNASDAQ:VTYXVentyx Biosciences Inc
08/03/202422h05Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:VTYXVentyx Biosciences Inc
07/03/202414h00GlobeNewswire Inc.Ventyx Biosciences Announces $100 Million Private Placement of Common StockNASDAQ:VTYXVentyx Biosciences Inc
07/03/202411h45PR Newswire (US)Class Action Filed Against Ventyx Biosciences, Inc. (VTYX) Seeking Recovery for Investors - Contact The Gross Law FirmNASDAQ:VTYXVentyx Biosciences Inc
06/03/202414h00GlobeNewswire Inc.Ventyx Biosciences to Participate in Two Upcoming Investor ConferencesNASDAQ:VTYXVentyx Biosciences Inc
04/03/202414h00GlobeNewswire Inc.Ventyx Biosciences to Host Virtual Investor Event on March 11, 2024NASDAQ:VTYXVentyx Biosciences Inc
27/02/202422h01GlobeNewswire Inc.Ventyx Biosciences Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent Corporate ProgressNASDAQ:VTYXVentyx Biosciences Inc
22/02/202413h00GlobeNewswire Inc.Ventyx Biosciences to Present Results of the Phase 2 Trial of VTX002 in Ulcerative Colitis at the 19th Congress of the European Crohn's and Colitis Organisation (ECCO)NASDAQ:VTYXVentyx Biosciences Inc
13/02/202422h09Edgar (US Regulatory)Form POSASR - Post-effective Amendment to an automatic shelf registration statementNASDAQ:VTYXVentyx Biosciences Inc
06/02/202422h05GlobeNewswire Inc.Ventyx Biosciences to Participate in the Oppenheimer 34th Annual Healthcare Life Sciences ConferenceNASDAQ:VTYXVentyx Biosciences Inc
02/01/202422h47Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:VTYXVentyx Biosciences Inc
21/12/202301h22Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:VTYXVentyx Biosciences Inc
21/11/202322h05GlobeNewswire Inc.Ventyx Biosciences to Participate in the 35th Annual Piper Sandler Healthcare ConferenceNASDAQ:VTYXVentyx Biosciences Inc
10/11/202314h00GlobeNewswire Inc.Ventyx Biosciences to Participate in the Jefferies London Healthcare ConferenceNASDAQ:VTYXVentyx Biosciences Inc
09/11/202322h01GlobeNewswire Inc.Ventyx Biosciences Reports Third Quarter 2023 Financial Results and Highlights Recent Corporate ProgressNASDAQ:VTYXVentyx Biosciences Inc
07/11/202312h33IH Market NewsKeep An Eye Out: Pre-Market Movers And Analyst RecommendationsNASDAQ:VTYXVentyx Biosciences Inc
 Showing the most relevant articles for your search:NASDAQ:VTYX

Dernières Valeurs Consultées

BIT
I09574
XS2690020933 20241031 11...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés